A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in Chronic Kidney Disease Clinical, Metabolic HealthANAD StaffJanuary 23, 2025
Cognitive and Alzheimer's Disease Biomarker Effects of Oral Nicotinamide Riboside (NR) Supplementation in Older Adults with Subjective Cognitive Decline and Mild Cognitive Impairment Clinical, Neurological HealthANAD StaffJanuary 15, 2025
Multi-Omics Characterization of Improved Cognitive Functions in Parkinson’s Disease Patients After The Combined Metabolic Activator Treatment Clinical, Neurological HealthANAD StaffJanuary 6, 2025
Feasibility of Telehealth Exercise and Nicotinamide Riboside Supplementation in Survivors of Childhood Cancer at Risk for Diabetes: A Pilot Randomized Controlled Trial Clinical, Metabolic HealthANAD StaffOctober 10, 2024
Acute Nicotinamide Riboside Supplementation Increases Human Cerebral NAD+ Levels In Vivo Clinical, Neurological HealthANAD StaffJuly 23, 2024
Nicotinamide Riboside for Peripheral Artery Disease: The NICE Randomized Clinical Trial Clinical, Cardiovascular Health, Aging & LongevityANAD StaffJune 13, 2024
Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults Clinical, Intravenous, Pharmacokinetic/SafetyANAD StaffJune 10, 2024
Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling Clinical, Inflammation/Immune HealthANAD StaffMarch 5, 2024
NR-SAFE: A Randomized, Double-Blind Safety Trial of High Dose Nicotinamide Riboside in Parkinson’s Clinical, Neurological HealthANAD StaffNovember 28, 2023Parkinson's Disease
A Randomized Placebo-Controlled Trial of Nicotinamide Riboside in Older Adults with Mild Cognitive Impairment Clinical, Neurological HealthANAD StaffNovember 23, 2023Neurological Health, Mild Cognitive Impairment
Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia Clinical, Neurological Health, Ataxia TelangiectasiaANAD StaffOctober 29, 2023Ataxia Telangiectasia, Neurological Health
Boosting NAD Preferentially Blunts Th17 Inflammation via Arginine Biosynthesis and Redox Control in Healthy and Psoriasis Subjects Clinical, Inflammation/Immune HealthANAD StaffAugust 15, 2023Immune Health
Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease Clinical, Metabolic HealthANAD StaffMay 9, 2023Metabolic Health
Oral Supplementation of Nicotinamide Riboside Alters Intestinal Microbial Composition in Rats and Mice, But Not Humans Clinical, Digestive & Gut HealthANAD StaffApril 3, 2023Digestive & Gut Health
Nicotinamide Riboside Supplementation is Not Associated with Altered Methylation Homeostasis in Parkinson’s Disease Clinical, Neurological Health, MethylationANAD StaffMarch 17, 2023Neurological Health, Parkinson's Disease, Methylation
Combined Metabolic Activators Improve Cognitive Functions in Alzheimer’s Disease Patients: A Randomized, Double-Blinded, Placebo-Controlled Phase-II Trial Clinical, Alzheimer's Disease, Neurological HealthANAD StaffJanuary 26, 2023Neurological Health, Alzheimer's Disease
Nicotinamide Riboside Improves Muscle Mitochondrial Biogenesis, Satellite Cell Differentiation, and Gut Microbiota in a Twin Study Clinical, Muscle HealthANAD StaffJanuary 13, 2023Muscle Health
Oral Nicotinamide Riboside Raises NAD+ and Lowers Biomarkers of Neurodegenerative Pathology in Plasma Extracellular Vesicles Enriched for Neuronal Origin Clinical, Neurological HealthANAD StaffDecember 14, 2022Neurological Health
Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction Clinical, Cardiovascular HealthANAD StaffSeptember 14, 2022Cardiovascular Health
The NADPARK Study: A Randomized Phase I Trial of Nicotinamide Riboside Supplementation in Parkinson’s Disease Clinical, Neurological HealthANAD StaffMarch 1, 2022Parkinson's Disease, Neurological Health
